Eisai to Present Latest Data on Perampanel at the 76th American Epilepsy Society (AES) Annual Meeting Nov 24, 2022 08:04 HKT/SGT Read More
To Develop Japan's First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research Nov 22, 2022 13:10 HKT/SGT Read More
Eisai to Present Full Findings from Lecanemab Confirmatory Phase 3 Clinical Trial (Clarity AD) and Other Alzheimer's Disease Research at The 15th Clinical Trials on Alzheimer's Disease (CTAD) Conference Nov 21, 2022 10:50 HKT/SGT Read More
エーザイ、第15回アルツハイマー病臨床試験会議(CTAD)において抗アミロイドβ(Aβ)プロトフィブリル抗体レカネマブの臨床第III相Clarity AD検証試験の詳細結果を含むアルツハイマー病領域のパイプラインに関する最新データを発表 Nov 21, 2022 10:30 JST Read More
American Journal of Gastroenterology Publishes Data from HighTide Therapeutics' Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis Nov 16, 2022 23:00 HKT/SGT Read More
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy Nov 11, 2022 17:00 HKT/SGT Read More
Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX Nov 07, 2022 15:49 HKT/SGT Read More
SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company Nov 04, 2022 17:47 HKT/SGT Read More